These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 17130199)
21. Neurophysiological role of sildenafil citrate (Viagra) on seminal parameters in diabetic males with and without neuropathy. Ali ST; Rakkah NI Pak J Pharm Sci; 2007 Jan; 20(1):36-42. PubMed ID: 17337426 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Alberty J; Oelerich M; Ludwig K; Hartmann S; Stoll W Laryngoscope; 2000 Jul; 110(7):1151-6. PubMed ID: 10892687 [TBL] [Abstract][Full Text] [Related]
23. Ganglioside therapy in diabetic neuropathy. Horowitz SH Muscle Nerve; 1986; 9(6):531-6. PubMed ID: 3526143 [TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Esquenazi A; Mayer NH; Elia AE; Albanese A Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335 [TBL] [Abstract][Full Text] [Related]
25. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Stong BC; DelGaudio JM; Hapner ER; Johns MM Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357 [TBL] [Abstract][Full Text] [Related]
26. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Schneider I; Thumfart WF; Pototschnig C; Eckel HE Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):31-5. PubMed ID: 8291857 [TBL] [Abstract][Full Text] [Related]
27. Cricopharyngeal myotomy normalizes the opening size of the upper esophageal sphincter in cricopharyngeal dysfunction. Yip HT; Leonard R; Kendall KA Laryngoscope; 2006 Jan; 116(1):93-6. PubMed ID: 16481817 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage. Krause E; Schirra J; Gürkov R Dysphagia; 2008 Dec; 23(4):406-10. PubMed ID: 18437465 [TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital. Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059 [TBL] [Abstract][Full Text] [Related]
31. Cricopharyngeal electromyography: patterns of injury based on etiology. Shemirani NL; Halum SL; Merati AL; Toohill RJ; Jaradeh S Otolaryngol Head Neck Surg; 2007 Nov; 137(5):792-7. PubMed ID: 17967648 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia. Silbergleit AK; Isabell K; Turnbull J; Patel N; Boettcher E; Konnai R; Collins D; Sidiropoulos C; Schultz L Dysphagia; 2023 Oct; 38(5):1421-1429. PubMed ID: 37071189 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection. Atkinson SI; Rees J J Otolaryngol; 1997 Aug; 26(4):273-6. PubMed ID: 9263899 [TBL] [Abstract][Full Text] [Related]
34. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899 [TBL] [Abstract][Full Text] [Related]
35. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Schroeder AS; Ertl-Wagner B; Britsch S; Schröder JM; Nikolin S; Weis J; Müller-Felber W; Koerte I; Stehr M; Berweck S; Borggraefe I; Heinen F Mov Disord; 2009 Jul; 24(10):1494-503. PubMed ID: 19489066 [TBL] [Abstract][Full Text] [Related]
36. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336 [TBL] [Abstract][Full Text] [Related]
37. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815 [TBL] [Abstract][Full Text] [Related]
38. Peripheric and automatic neuropathy in children with type 1 diabetes mellitus: the effect of L-carnitine treatment on the peripheral and autonomic nervous system. Uzun N; Sarikaya S; Uluduz D; Aydin A Electromyogr Clin Neurophysiol; 2005; 45(6):343-51. PubMed ID: 16315971 [TBL] [Abstract][Full Text] [Related]
39. Effect of botulinum toxin injection for achalasia in Thai patients. Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248 [TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. Schrey A; Airas L; Jokela M; Pulkkinen J J Neurol Sci; 2017 Sep; 380():142-147. PubMed ID: 28870555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]